Spruce Street Capital LP
CIK 0002050194 · NEW YORK, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-13 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$509.7M
2026 Q2
Positions
30
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
70.2%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
KNSA
KINIKSA PHARMACEUTICALS INTL
11.5%
RLAY
RELAY THERAPEUTICS INC
11.0%
LBRX
LB PHARMACEUTICALS INC
8.8%
RLMD
RELMADA THERAPEUTICS INC
8.7%
ANRO
ALTO NEUROSCIENCE INC
7.0%
DNTH
DIANTHUS THERAPEUTICS INC
6.8%
ALKS
ALKERMES PLC
5.6%
SVRA
SAVARA INC
4.2%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.